A Post-Marketing Near Real-Time Safety Surveillance of Respiratory Syncytial Virus Vaccine for Guillain-Barre Syndrome (GBS) among Older Adults in the United States

16/08/2024
28/07/2025
EU PAS number:
EUPAS1000000267
Study
Ongoing
Documents
Study protocol
Initial protocol
English (1.04 MB - PDF) View document
Updated protocol
English (1.61 MB - PDF) View document
Study results
Study report
Other information